Daily Medication Pearl: Glatiramer Acetate Injection (Copaxone) for Multiple Sclerosis

Article

Glatiramer acetate modifies immune processes that are believed to be responsible for the pathogenesis of multiple sclerosis.

Medication Pearl of the Day: Glatiramer acetate injection (Copaxone)

Glatiramer acetate is indicated for the treatment of relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Explanations:

  • Dosage: For subcutaneous injection only; doses are not interchangeable
    • Glatiramer acetate 20 mg/ml per day
    • Glatiramer acetate 40 mg/mL 3 times per week
  • Dosage forms: Injection of 20 mg/mL in a single-dose, prefilled syringe with a white plunger. Injection of 40 mg/mL in a single-dose, prefilled syringe with a blue plunger.
  • Adverse events: Injection site reactions, vasodilatation, rash, dyspnea, and chest pain.
  • Mechanism of action: Glatiramer acetate is thought to act by modifying immune processes that are believed to be responsible for the pathogenesis of MS.
  • Manufacturer: Teva

Sources

Related Videos
Image credit:  Chanintorn.v | stock.adobe.com - PTSD Mental health concept, Psychologist sitting and touch hand young depressed asian man for encouragement near window with low light environment.Selective focus.
Image credit: сергей костюченко | stock.adobe.com - human head with brain
Health care provider examining MRI images of patient with multiple sclerosis -- Image credit: New Africa | stock.adobe.com
Image Credit: SciePro - stock.adobe.com
Pharmacist selling medications in the pharmacy | Image Credit: rh2010 - stock.adobe.com
Atopic dermatitis on a patient's hand -- Image credit: Ольга Тернавская | stock.adobe.com
biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book | Image Credit: lexiconimages - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.